C Ray Therapeutics raises $100 million to develop radiopharmaceuticals
By Clara Rodriguez Fernandez
News & Analysis on Clinical Trial Services & Contract Research And Development
Trends
Bioavailbility challenge
More→
Promotional features
More→
Streamlining early phase drug development with continuous flow technologies
Paid for and in partnership with Lonza Small Molecules
Achieving data integrity: Best practices for secure and reliable data management
Paid for and content provided by METTLER TOLEDO
AI transforms route scouting for faster drug synthesis
Paid for and in partnership with Lonza Small Molecules
Decentralized clinical trials: The trends, the market and the future
Paid for and content provided by DHL Supply Chain
Clinical evolution
More→
Gilead recruits Terray in AI-driven drug discovery pact
By Jonathan Smith
AbbVie acquires Roche immune drug spinout in $200 million deal
By Clara Rodriguez Fernandez
Noema Pharma raises $147 million to develop drugs for neurological conditions
By Clara Rodriguez Fernandez
Globalization
More→
Patient centricity
More→
Palatin reports positive phase 2b results in type 2 diabetic nephropathy
By Clara Rodriguez Fernandez
AstraZeneca claims phase 3 success with combination therapy for prostate cancer
By Clara Rodriguez Fernandez
Transparency on trial
More→
